Clinical outcomes of unrestricted application of domestic Sirolimus-eluting stent
- VernacularTitle:真实临床条件下国产西罗莫司药物支架的临床评价
- Author:
Xin CHEN
;
Shuzheng LU
;
Yundai CHEN
- Publication Type:Journal Article
- Keywords:
Cardiac disease;
Stents;
Evaluation studies;
Sirolimus
- From:
Chinese Journal of Interventional Cardiology
2003;0(06):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To ivestigate the clinical outcomes of domestic Sirolimus-eluting stents(Partner stents)in unselected patients.Methods We reviewed the clinical data of 516 patients who had implanted the Paterner stents during August 2006 to Dotober 2007.We followed up all the patients by telephon or by clinical visits for(9?2)months.The incidence of MACE and the result of follow up angiogram was analysed.Further investigation was made in the relation between the restenosis rate and lesion morphorlogy.Results A total of 872 Partner Stents were implanted successfully in 516 patients.Among them,482 patients(93.4%)finished the clinical follow up and 239 patients(46.3%)received follow up angiogram.The MACE rate was 3.5% and the restenosis rate was 11.3% as share in angiogram.A 14% of the patients with reslenosis was concomitant with diabetes mellitus.We analysised the rate of restenoses of left main,bifurcation,chronic total occlusion,diffuse disease,in-stent restenoses,littile vessal,acute occlusion,ostial lesions,and just A-just lesion.Conclusion Implantation of domestic Partner stent was safe and effective,even in patients with diabetes mellitus.The MACE rate was low and the stent has shown satisfactory ontcomes in lesions such as left main,bifurcation,chronic total occlusion,diffuse disease,in-stent restenoses,littile vessal,acute occlusion,ostial lesions,and A-type lesion.
